DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Bynfezia Pen is a drug marketed by Sun Pharm and is included in one NDA. There is one patent protecting this drug.
This drug has five patent family members in five countries.
The generic ingredient in BYNFEZIA PEN is octreotide acetate. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
A generic version of BYNFEZIA PEN was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.
Pharmacology for BYNFEZIA PEN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sun Pharm||BYNFEZIA PEN||octreotide acetate||SOLUTION;SUBCUTANEOUS||213224-001||Jan 28, 2020||RX||Yes||Yes||Try Before You Buy||Try Before You Buy||Y||Try Before You Buy|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Country||Patent Number||Estimated Expiration|
|European Patent Office||3624829||Try Before You Buy|
|South Korea||20200003923||Try Before You Buy|
|China||110678194||Try Before You Buy|
|Brazil||112019023981||Try Before You Buy|
|World Intellectual Property Organization (WIPO)||2018211526||Try Before You Buy|
|>Country||>Patent Number||>Estimated Expiration|